Medicus International has been successfully developing global communications for 30 years.
Medicus International has been successfully delivering global communications for 30 years. Our philosophy is to develop inspired strategic solutions through an understanding of market opportunity and trends, product differentiation and required target audience reach. This has established us as experts in defining global communications strategies that deliver brand success.
We believe that we have pioneered the first truly successful approach to delivering marketing solutions to international pharmaceutical clients. With dedicated client service teams based in London and New York, we have extensive experience in supporting pre-launch, launch and post-launch phases in all major therapy areas. These encompass allergy, CV disease, CNS disease (including schizophrenia and depression), diabetes, fertility, gastroenterology, infectious diseases (including HIV), oncology, osteoporosis, pain, respiratory, rheumatology, and transplantation.
Our core services include:
As part of the Publicis Healthcare Communications Group, Medicus International is supported by the largest worldwide healthcare network, including Medicus and Discovery offices and the Saatchi & Saatchi Healthcare Group.
For further details contact
Peneli Oliver, Managing Director
peneli.oliver@medicusgroup.com
Jane Smith, Director of Client Services
jane.smith@medicusgroup.com
Or visit www.medicus-international.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.